Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 305, Issue -, Pages -Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2022.116112
Keywords
Buyang Huanwu Decoction; Cerebral ischemia-reperfusion; Multi-omics; 4D-parallel reaction monitoring
Categories
Funding
- National Key R & D Projects of China [2019YFC1708600, 2019YFC1708604]
- National Natural Science Foundation of China [81630105]
- Key Laboratory of TCM Encephalopathy of Zhejiang Province [2020E10012]
Ask authors/readers for more resources
This study aims to explore the potential targets of Buyang Huanwu Decoction (BYHW) in the treatment of cerebral ischemia-reperfusion (I/R) using multi-omics analysis methods. Rats with middle cerebral artery occlusion (MCAO) were used to study the effect of BYHW on cerebral I/R injury and analyze potential targets and pathways. The results identified several potential targets and pathways involved in the treatment of cerebral I/R injury.
Ethnopharmacological relevance: Buyang Huanwu Decoction (BYHW) is a classic representative formula for treating qi deficiency and the blood stasis syndrome of stroke in the Qing Dynasty physician Wang Qingren's Correction on the Errors of Medical Works. However, the research on the mechanism of BYHW in the treatment of stroke is not systematic and comprehensive.Aim of the study: Combined with multi-omics analysis methods to explore the potential targets of BYHW in the treatment of cerebral ischemia-reperfusion (I/R).Materials and methods: The rat middle cerebral artery occlusion (MCAO) model was established to study the effect of BYHW on cerebral I/R injury in rats. Then, the potential targets and pathways of BYHW in the treatment of cerebral I/R injury were analyzed by proteomic, transcriptomic, and metabolomic methods. Finally, 4D-PRM was used to validate potential targets. Results: BYHW effectively improved the neurological function scores of MCAO rats and significantly reduced the rate of cerebral infarction in MCAO rats. Multi-omics analysis had identified 15 potential targets and 4 potential signaling pathways. The results of 4D-PRM targeted proteomics verification showed that Pde1b was reversed upregulated, and Aprt, Gpd1, Glb1, HEXA, and HEXB were reversed down-regulated.Conclusion: BYHW may improve cerebral I/R through Aprt, Pde1b, Gpd1, Glb1, HEXA and HEXB targets, and Glycerophospholipid metabolism, Purine metabolism and Glycosphingolipid biosynthesis - globoseries pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available